➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Moodys
Harvard Business School
Boehringer Ingelheim
McKesson
Colorcon

Last Updated: September 23, 2020

DrugPatentWatch Database Preview

Patent: 8,033,916

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,033,916
Title:Grip pressure sensor
Abstract: Grip pressure is monitored by a collection of battery powered components embodied in an assembly analogous to an ordinary wrist watch, that is a watch housing or casement and a stretchable band. The system, which we shall refer to as a swing monitor, is worn on the wrist and deployed in such a way that the back of the housing or casement is cinched securely to the back or underside of the wrist. A pressure plate on the back of the watch makes contact with the pulse region of the wrist. The flexing and relaxing of the muscles and tendons of the wearer is read by an electronic pressure sensing device, a piezo sensor. A tighter grip will register greater pressure and a looser grip, less pressure. The device records grip pressure associated with the swing of a golf club, tennis racquest or baseball bat, among other articles of sports equipment meant to be swung. The grip pressure determined to be optimal, that is giving the desired result, can be SAVED in the memory of the swing monitor system. Subsequent swings and their associated grip pressures are compared with the SAVED value of the optimal or best swing. An audible signal alerts the wearer if the grip pressure departs from that registered on the optimal or best swing.
Inventor(s): Caldwell; Theodore (Laguna Beach, CA), Chen; Ning (Yorba Linda, CA)
Assignee:
Application Number:11/733,145
Patent Claims:see list of patent claims

Details for Patent 8,033,916

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Emergent Biosolutions Canada Inc. BAT botulism antitoxin heptavalent LIQUID 125462 1 2013-03-01   Start Trial 2040-01-29 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Merck
Medtronic
Mallinckrodt
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.